Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis

REFERENCES

• Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Scfilaak M, Muller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 1997; 156: 1586-92.
   PubMed Web of Science ®Google Scholar
• Muller-Quernheim J, Pfeifer S, Manuel D, Straus J, Ferlinz R. Lung restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Rcspir Dis 1992; 145: 187-92.
   PubMedGoogle Scholar
• Agostini C, Semenzato G. Cytokines in sarcoidosis. Semin Respir Infect 1998; 13: 184-96.
   PubMedGoogle Scholar
• Agostini C, Costabel U, Semenzato G. Sarcoidosis news: immunologic frontiers for new immunosuppressive strategies. Clin Immunol Immunopathol 1988; 88: 199-204.
   Google Scholar
• Semenzato G, Bortoli M, Agostini C. Applied clinical immunology in sarcoidosis. Curr Opin Pulm Med 2002; 8: 441-4.
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Gilbert S, Pueringer R, Dayton C, Flocrchingcr C, Helmers R, Merchant R, Wilson J, Galvin J, Schwartz D. Outcome of the treatment for sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-8.
   PubMed Web of Science ®Google Scholar
• Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM. Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 1955; 270: 2198-202.
   Google Scholar
• Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 1995; 270: 26252-6.
   PubMed Web of Science ®Google Scholar
• Den Tandt WR, van Hoof F. Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients. J Inherit Metab Dis 1996; 19: 344-50.
   PubMed Web of Science ®Google Scholar
• Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br J Med 1961; 2: 1165-72.
   PubMed Web of Science ®Google Scholar
• Costabel U, Teschlcr H. Biochemical changes in sarcoidosis. Clin Chest Med 1997; 18: 827-42.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Shijubo N, Ohmichi M, Kamiguchi K, Takahashi R, Morita-Ichimura S, Ohchi T, Tatsuno T, Hiraga Y, Abe S, Sato N. Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis. Clin Exp Immunol 2003; 132: 152-7.
   PubMed Web of Science ®Google Scholar
• Lawrence EC, Brousseau KP, Berger MB, Kurman CC, Marcon L, Nelson DL. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis 1988; 137: 759-64.
   PubMed Web of Science ®Google Scholar
• Muller-Qucrnheim J, Pfeifer S, Strausz J, Ferlinz R. Correlation of clinical and immunologic parameters of the inflammatory activity of pulmonary sarcoidosis. Am Rev Respir Disc 1991: 144: 1322-9.
   PubMedGoogle Scholar
• Harada T, Amano T, Takahashi A, Furuya J, Yamaguchi E, Kaji M, Morikawa T, Itoh T, Shimizu M, Nishimura M. Necrotizing sarcoid granulomatosis presenting with elevated serum soluble interleukin-2 receptor levels. Respiration 2002; 69: 468-70.
   PubMed Web of Science ®Google Scholar
• Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, Matsukura S, Kohno S. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52-7.
   PubMed Web of Science ®Google Scholar
• Tajima S, Sando Y, Maeno T, Sagawa N, Nara M, Maeno Y, Nakagawa J, Ito T, Hoshino Y, Suga T, Arai M, Kurabayashi M. Increased serum thymidine kinase activity in acute sarcoidosis. Intern Med 2002; 41: 129-32.
   PubMed Web of Science ®Google Scholar
• Shijubo N, Itoh Y, Yamaguchi T, Abe S. Development of an enzyme-linked immunosorbent assay for Clara cell 10-kDa protein: in pursuit of clinical significance of sera in patients with asthma and sarcoidosis. Ann N Y Acad Sci 2002; 923: 268-79.
   Web of Science ®Google Scholar
• Lieberman J. Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis. Am J Med 1975; 59: 365-72.
   PubMed Web of Science ®Google Scholar
• Rohatgi PK. Significance of serum angiotensin converting enzyme and gallium scan in noninvasive diagnosis of sarcoidosis. Eur J Respir Dis 1981; 62: 223-30.
   PubMedGoogle Scholar
• Rossman MD, Dauber JH, Cardillo ME, Daniele RP. Pulmonary sarcoidosis: correlation of serum angiotensin-convcrting enzyme with blood and bronchoalveolar lymphocytes. Am Rev Respir Dis 1982; 125: 366-9.
   PubMedGoogle Scholar
• Allen RK. A review of angiotensin converting enzyme in health and disease. Sarcoidosis 1991; 8: 95-100.
   PubMedGoogle Scholar
• Brice EA, Friedlander W, Bateman ED, Kirsch RE. Serum angiotensin-converting enzyme activity, concentration, and specific activity in granulomatous interstitial lung disease, tuberculosis, and COPD. Chest 1995; 107: 706-10.
   PubMed Web of Science ®Google Scholar
• Schurmann M, Reichel P, Mullcr-Myhsok B, Schlaak M, Muller-Qucrnheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164: 840-6.
   PubMed Web of Science ®Google Scholar
• Schurmann M, Reichel P, Mullcr-Myhsok B, Dieringer T, Wurm K, Schlaak M, Muller-Quernheim J, Schwinger E. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 2001; 249: 77-83.
   PubMed Web of Science ®Google Scholar
• Planck A, Eklund A, Yamaguchi E, Grunewald J. Angiotensin-converting enzyme gene polymorphism in relation to HLA-DR in sarcoidosis. J Intern Med 2002; 251: 217-22.
   PubMed Web of Science ®Google Scholar
• Rohrbach MS, DeRemee RA. Pulmonary sarcoidosis and serum angiotensin-converting enzyme. Mayo Clin Proc 1982; 57: 64-6.
   PubMed Web of Science ®Google Scholar
• Romer FK. Angiotensin-converting enzyme activity in sarcoidosis and other disorders. Sarcoidosis 1985; 2: 25-34.
   PubMedGoogle Scholar
• Shorr AF, Torrington KG, Parker JM. Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis. Respir Med 1997; 91: 399-401.
   PubMed Web of Science ®Google Scholar
• Ucar G, Yildirim Z, Ataol E, Erdogan Y, Biber C. Serum angiotensin converting enzyme activity in pulmonary diseases: correlation with lung function parameters. Life Sci 1997; 61: 1075-82.
   PubMed Web of Science ®Google Scholar
• Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994; 93: 1288-92.
   PubMed Web of Science ®Google Scholar
• Casal JA, Lacerda L, Perez LF, Pinto RA, Clara Sa Miranda M, Carlos Tutor J. Relationships between serum markers of monocyte/ macrophage activation in type 1 Gaucher’s disease. Clin Chem Lab Med 2002; 40: 52-5.
   PubMed Web of Science ®Google Scholar
• Sharma OP, Ratto D. Pulmonary sarcoidosis: radiographic features. Clin Dermatol 1986; 4: 96-107.
   PubMedGoogle Scholar
• Den Tandt WR, Van Hoof F. Plasma methyl-umbelliferyl-tetra-N-acetyl-beta-d-chitotetraoside hydrolase as a parameter during treatment of Gaucher patients. Biochem Mol Med 1996; 57: 71-2.
   PubMedGoogle Scholar